Double Medical Technology Inc (002901) - Net Assets

Latest as of March 2026: CN¥3.85 Billion CNY ≈ $564.05 Million USD

Based on the latest financial reports, Double Medical Technology Inc (002901) has net assets worth CN¥3.85 Billion CNY (≈ $564.05 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥5.03 Billion ≈ $735.99 Million USD) and total liabilities (CN¥1.18 Billion ≈ $171.94 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Double Medical Technology Inc (002901) tangible equity ratio to evaluate the tangible quality of the company's equity base.

Key Net Assets Metrics

Metric	Value
Current Net Assets	CN¥3.85 Billion
% of Total Assets	76.64%
Annual Growth Rate	26.26%
5-Year Change	42.38%
10-Year Change	535.25%
Growth Volatility	29.34

Double Medical Technology Inc - Net Assets Trend (2013–2025)

This chart illustrates how Double Medical Technology Inc's net assets have evolved over time, based on quarterly financial data. See Double Medical Technology Inc defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Annual Net Assets for Double Medical Technology Inc (2013–2025)

The table below shows the annual net assets of Double Medical Technology Inc from 2013 to 2025. For live valuation and market cap data, see 002901 market cap overview.

Year	Net Assets	Change
2025-12-31	CN¥3.69 Billion ≈ $539.27 Million	+15.83%
2024-12-31	CN¥3.18 Billion ≈ $465.57 Million	+0.66%
2023-12-31	CN¥3.16 Billion ≈ $462.50 Million	+1.75%
2022-12-31	CN¥3.11 Billion ≈ $454.56 Million	+20.01%
2021-12-31	CN¥2.59 Billion ≈ $378.76 Million	+21.30%
2020-12-31	CN¥2.13 Billion ≈ $312.26 Million	+21.70%
2019-12-31	CN¥1.75 Billion ≈ $256.59 Million	+20.28%
2018-12-31	CN¥1.46 Billion ≈ $213.33 Million	+17.71%
2017-12-31	CN¥1.24 Billion ≈ $181.24 Million	+113.49%
2016-12-31	CN¥580.13 Million ≈ $84.89 Million	+31.31%
2015-12-31	CN¥441.78 Million ≈ $64.65 Million	+61.03%
2014-12-31	CN¥274.36 Million ≈ $40.15 Million	+22.15%
2013-12-31	CN¥224.61 Million ≈ $32.87 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Double Medical Technology Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have grown by 1014.1% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2025)

Component	Amount	Percentage
Retained Earnings	CN¥1.93 Billion	53.93%
Other Components	CN¥1.64 Billion	46.07%
Total Equity	CN¥3.57 Billion	100.00%

Double Medical Technology Inc Competitors by Market Cap

The table below lists competitors of Double Medical Technology Inc ranked by their market capitalization.

Company	Market Cap
Anhui Wanwei Updated High-tech Material Industry Co Ltd SHG:600063	$2.56 Billion
Quaker Chemical Corporation NYSE:KWR	$2.56 Billion
Central Puerto S.A. BA:CEPU	$2.56 Billion
Fraser Neave Holdings Bhd KLSE:3689	$2.56 Billion
Petrosea Tbk JK:PTRO	$2.56 Billion
Voltronic Power Technology Corp TW:6409	$2.56 Billion
DHT Holdings Inc NYSE:DHT	$2.56 Billion
Suzhou Nanomicro Technology Co Ltd SHG:688690	$2.56 Billion

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Double Medical Technology Inc's equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from 3,078,989,111 to 3,570,001,649, a change of 491,012,538 (15.9%).
Net income of 599,631,710 contributed positively to equity growth.
Dividend payments of 214,358,242 reduced retained earnings.
Other comprehensive income decreased equity by 408,423,700.
Other factors increased equity by 514,162,771.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	CN¥599.63 Million	+16.8%
Dividends Paid	CN¥214.36 Million	-6.0%
Other Comprehensive Income	CN¥-408.42 Million	-11.44%
Other Changes	CN¥514.16 Million	+14.4%
Total Change	CN¥-	15.95%

Book Value vs Market Value Analysis

This analysis compares Double Medical Technology Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 4.90x
The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
The price-to-book ratio has decreased from 60.26x to 4.90x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2013-12-31	CN¥0.70	CN¥42.27	x
2014-12-31	CN¥0.68	CN¥42.27	x
2015-12-31	CN¥1.37	CN¥42.27	x
2016-12-31	CN¥1.60	CN¥42.27	x
2017-12-31	CN¥3.32	CN¥42.27	x
2018-12-31	CN¥3.61	CN¥42.27	x
2019-12-31	CN¥4.30	CN¥42.27	x
2020-12-31	CN¥5.26	CN¥42.27	x
2021-12-31	CN¥6.23	CN¥42.27	x
2022-12-31	CN¥7.25	CN¥42.27	x
2023-12-31	CN¥7.26	CN¥42.27	x
2024-12-31	CN¥7.42	CN¥42.27	x
2025-12-31	CN¥8.62	CN¥42.27	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Double Medical Technology Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 16.80%
The company demonstrates strong efficiency in generating profits from shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 23.06%
• Asset Turnover: 0.53x
• Equity Multiplier: 1.38x
Recent ROE (16.80%) is below the historical average (26.28%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2013	43.20%	47.77%	0.68x	1.32x	CN¥74.40 Million
2014	51.35%	46.60%	0.55x	2.01x	CN¥112.17 Million
2015	42.97%	48.15%	0.70x	1.28x	CN¥144.76 Million
2016	38.22%	47.41%	0.64x	1.25x	CN¥161.94 Million
2017	24.08%	49.76%	0.43x	1.13x	CN¥172.83 Million
2018	25.80%	48.09%	0.46x	1.16x	CN¥227.46 Million
2019	27.03%	37.02%	0.56x	1.30x	CN¥293.31 Million
2020	28.79%	38.17%	0.60x	1.26x	CN¥395.29 Million
2021	26.80%	33.76%	0.59x	1.35x	CN¥422.06 Million
2022	3.09%	6.45%	0.36x	1.31x	CN¥-207.42 Million
2023	1.93%	3.85%	0.33x	1.52x	CN¥-246.89 Million
2024	11.59%	16.71%	0.48x	1.44x	CN¥48.90 Million
2025	16.80%	23.06%	0.53x	1.38x	CN¥242.63 Million

Industry Comparison

This section compares Double Medical Technology Inc's net assets metrics with peer companies in the Medical Devices industry.

Industry Context

Industry: Medical Devices
Average net assets among peers: $1,198,702,887
Average return on equity (ROE) among peers: 15.43%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Double Medical Technology Inc (002901)	CN¥3.85 Billion	43.20%	0.30x	$2.56 Billion
Shanghai Kehua Bio-Engineering Co Ltd (002022)	$1.09 Billion	22.08%	0.18x	$371.06 Million
Jiangsu Yuyue Medical Equipment & Supply Co Ltd (002223)	$154.18 Million	20.46%	1.55x	$3.63 Billion
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A (002932)	$115.39 Million	30.85%	0.16x	$506.97 Million
Lepu Medical Tech Beijing (300003)	$2.89 Billion	12.49%	0.08x	$3.19 Billion
INKON Life Technology Co Ltd (300143)	$2.07 Billion	2.43%	0.27x	$764.39 Million
Edan Instruments Inc (300206)	$1.16 Billion	1.16%	0.17x	$1.15 Billion
Guangdong Biolight Meditech Co Ltd (300246)	$89.93 Million	36.68%	0.42x	$735.30 Million
Beijing Leadman Biochemistry Co Ltd (300289)	$1.98 Billion	1.13%	0.19x	$467.29 Million
Sinocare Inc (300298)	$1.24 Billion	11.58%	0.08x	$1.17 Billion

About Double Medical Technology Inc

SHE:002901 China Medical Devices

Market Cap

$2.56 Billion

CN¥17.50 Billion CNY

Market Cap Rank

#5522 Global

#1090 in China

Share Price

CN¥42.27

Change (1 day)

+1.51%

52-Week Range

CN¥35.38 - CN¥62.68

All Time High

CN¥114.55